Rock Springs Capital Management LP Nuvalent, Inc. Transaction History
Rock Springs Capital Management LP
- $1.47 Billion
- Q2 2025
A detailed history of Rock Springs Capital Management LP transactions in Nuvalent, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 93,328 shares of NUVL stock, worth $7.15 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
93,328
Previous 427,532
78.17%
Holding current value
$7.15 Million
Previous $30.3 Million
76.52%
% of portfolio
0.48%
Previous 1.81%
Shares
5 transactions
Others Institutions Holding NUVL
# of Institutions
226Shares Held
59.5MCall Options Held
277KPut Options Held
255K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.38 Billion31.57% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$404 Million18.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$232 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.8MShares$138 Million0.02% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.29B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...